Curtis Drug Point Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-01-2025
- Paid Up Capital ₹ 4.50 Cr
as on 16-01-2025
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.30 Cr
as on 16-01-2025
- Revenue -5.05%
(FY 2023)
- Profit 49.35%
(FY 2023)
- Ebitda -32.39%
(FY 2023)
- Net Worth -33.20%
(FY 2023)
- Total Assets -16.15%
(FY 2023)
About Curtis Drug Point
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹6.30 Cr.
Sundararaj Chandrakumar, Pandurangan Selvaraj, and Aravindan Selvaraj serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC119150
- Company No.
119150
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2017
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Curtis Drug Point?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundararaj Chandrakumar  | Director | 31-Oct-2017 | Current |
| Pandurangan Selvaraj | Director | 18-Oct-2017 | Current |
| Aravindan Selvaraj | Director | 01-Oct-2018 | Current |
Financial Performance of Curtis Drug Point.
Curtis Drug Point Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.05% decrease. The company also saw a substantial improvement in profitability, with a 49.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curtis Drug Point?
In 2023, Curtis Drug Point had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yashomati Hospitals Private LimitedActive 17 years 10 monthsSundararaj Chandrakumar is a mutual person
Kmc Speciality Hospitals (India) LimitedActive 42 years 24 daysSundararaj Chandrakumar is a mutual person
- Kauvery Health Enterprises Private LimitedActive 9 years 3 months
Sundararaj Chandrakumar is a mutual person
- Sri Kauvery Medical Care (India) LimitedActive 27 years 1 month
Sundararaj Chandrakumar, Pandurangan Selvaraj and 1 more are mutual person
Charges (Loans)
₹6.30 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 6.00 Cr
- Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2022 | Hdfc Bank Limited | ₹3.00 M | Open |
| 13 Nov 2019 | State Bank Of India | ₹6.00 Cr | Open |
How Many Employees Work at Curtis Drug Point?
Curtis Drug Point has a workforce of 40 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curtis Drug Point, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curtis Drug Point's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
